CRVO (cervomed.com) Net Income

Corporate emblem and logo of CervoMed (CRVO)

CervoMed Inc. (CRVO) margin efficiency is based on the automation of drug synthesis via IT platforms. The company's annual net profit on this GURU.Markets platform chart reflects revenue dynamics, where the -0.03 mark serves as a key metric. The creation of a unique system to combat dementia provides hope to patients, and the completion of phase II trials should attract a major strategic partner or buyer.

Company Net Income: CervoMed Corporation (CRVO) for 02/21/2024 - 11/01/2026

Analytical breakdowns and data insights for company CervoMed (CRVO)

- stock value and consensus price forecast:
Market Price CervoMed Corporation|CRVO - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation CervoMed Corporation|CRVO - Enterprise Value
- company book value details:
Net Asset Value per Share CervoMed|CRVO - Company Book Value|Market Value to Book Value cervomed.com|CRVO - Cumulative Company Assets
- debt burden and liquidity indicators:
Debt to Equity CervoMed Inc.|CRVO - Long-Term Debt to Equity|Current Liabilities to Capital CervoMed, Inc.|CRVO - Company Debts|Debt to Book Value CervoMed Corporation|CRVO - Company Long-Term Debts|Short-Term Debt CervoMed|Immediate Liquidity Ratio cervomed.com
- company profitability and valuation multiples indicators:
CRVO - Net Income
Basic company analysis:CRVO, CervoMed Corporation
Finished products of CervoMed Inc.

Monitoring operating profit allows for an assessment of cost management efficiency relative to generated demand, determining the business's ability to scale profitability without capital loss. Analyzing this financial performance metric for CervoMed Inc. (CRVO) reveals that the absence of commercial sales amid the expansion of clinical trials keeps profit in negative territory, rendering the asset a high-risk speculative instrument.

Direct competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Income regencellbioscience.com (RGC)|Net Profit AXSM|ACAD - Company Net Income|Company Net Income Xenon Pharmaceuticals Inc XENE|Final Profit VKTX|SUPN: Net Income|CPRX: Company Net Income|Denali Therapeutics Inc. (DNLI) - Company Net Income|Company Net Income Harmony Biosciences Inc (HRMY)|Company Net Income Biohaven Pharmaceutical|Net Income Amylyx Corp (AMLX)|Net Profit TRVI|PRAX - Company Net Income|Net Profit AVXL (Anavex Life Sciences Corp.)|CBLL: Company Profit|PRTA: Net Income|Final Profit ALEC (Alector, Inc.)|ANNX: Net Profit|OMER - Net Financial Result|Company Net Income Neurogene|Company Profit ACIU (AC Immune S.A.)|Net Profit VYGR|Net Income Neumora Corp NMRA|Scilex Holding Company - Net Income|Net Financial Result tevogen.com (TVGN)|Alpha Cognition Corp - Net Profit|cogrx.com (CGTX) - Net Income|Inhibikase (IKT) - Company Net Income|Cassava Pharma - Final Profit|Net Income ASRT|Company Net Income COYA|Company Net Income Vistagen Therapeutics (VTGN)|OVID - Company Net Income|Company Net Income Acumen Pharma ABOS|ATHE: Company Profit|Clene Nanomedicine - Net Profit|Company Net Income PepGen Inc.|JUNS (Jupiter Neurosciences Inc) - Net Income|Relmada Therapeutics Inc (RLMD) - Net Profit|Company Net Income Annovis Bio Corp|GRCE: Final Profit|Company Net Income Firefly Neuroscience, Inc (AIFF)|KLTO - Company Net Income|Net Profit NRSN (NeuroSense Therapeutics Ltd.)|RVPH - Net Income|MetaVia, Inc. - Net Profit|Company Net Income NeurAxis Inc|heliusmedical.com (HSDT) - Company Net Income|Passage Bio - Final Profit|Net Income NEUP|Company Net Income NERV|Company Net Income Athira (ATHA)|ADXN - Company Net Income|Company Net Income Alzamend Neuro ALZN|CYCN - Net Income|Protagenic - Net Profit|Company Net Income Pasithea Therapeutics|CRGT: Net Profit|Company Profit ATXI|Net Income BCLI|CARA: Final Profit|Net Profit CHRO|Net Financial Result eliemtx.com|Company Net Income Intra-Cellular Therapies, Inc. ITCI|LBPH: Company Profit|Marinus Pharmaceuticals - Net Profit|nkgenbiotech.com (NKGN) - Net Income|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net Income|SAGE - Net Financial Result|SNPX (Neurotrope) - Net Profit|Net Income Trevena Inc (TRVN)|Company Net Income Vigil Neuroscience (VIGL)|WENA (Anew Medical Inc.) - Final Profit|Cerevel Therapeutics, Inc. - Net Income